Chemical Profiling and Evaluation of Antioxidant and Neurodegenerative Enzyme Inhibitory Potential of Flavonol and Flavonol Glycoside Fractions of Cranberry Pomace and Fruit Extracts
By: Elena De Pra
Abstract
The imbalance between reactive oxygen species and antioxidant defense is often implicated in neuronal damage associated with neurodegenerative diseases like Alzheimer’s and Parkinson’s. Quercetin, a naturally occurring flavonoid, has been extensively studied for its promising neuroprotective potential due to its ability to effectively combat oxidative stress as a potent antioxidant. Typically found in the standard diet as quercetin glycosides in foods such as cranberries, quercetin is known for its free radical scavenging abilities, though its poor bioavailability limits its therapeutic effectiveness. This research aimed to investigate the antioxidant and enzymatic inhibitory potential of two fractions isolated from cranberry pomace and cranberry fruit extract containing quercetin and quercetin-3-galactoside, respectively. The extracts were profiled for polyphenolic compounds, and the desired flavonoids were isolated and confirmed using high-performance liquid chromatography (HPLC). Antioxidant activity was assessed using DPPH, ABTS free radical scavenging, and FRAP reducing power assays. Results demonstrate that the aglycone quercetin fraction exhibited higher antioxidant capacity than the quercetin-3-galactoside fraction. The quercetin fraction also demonstrated strong inhibitory activity against acetylcholinesterase. Future research will evaluate the inhibitory effect of these fractions to inhibit other enzymes associated with neurodegenerative diseases, including butyrylcholinesterase and monoamine oxidase A/B. Results from this study aim to shed light on how glycosylation may influence therapeutic potential with respect to inhibitory effects, to link antioxidant activity to neuroprotection.
Introduction
Neurodegenerative disorders represent a critical public health crisis affecting millions of individuals regardless of age, sex, education, or income. The World Health Organization (WHO) estimates 6.8 million people die per year of neurological disorders1. The significance of this issue grows as human life spans extend, making elderly populations increasingly vulnerable to neurological diseases like Alzheimer’s and Parkinson’s. This topic is sensitive not only to directly affected individuals, but also to their families, caregivers, and society at large, who fear the uncertainties of aging. Modern therapeutics focus on symptom management, as no treatments currently exist that reverse neuronal death or effectively delay progression.
Natural products have been used for thousands of years in traditional medicine for their biological and pharmacological properties. Natural product-derived compounds show promising potential in drug development for their role in treating neurodegenerative disorders, particularly attributed to their polyphenolic content2. Polyphenolic compounds are proven to have neuroprotective effects, notably through their capacity to neutralize reactive oxygen species, characteristic of their antioxidant activity2. Consuming these naturally occurring compounds, rich in various fruits and vegetables, is a preferred alternative over pharmaceutical drugs as it has both restorative and preventative potential without adverse effects (Fig. 1).

Fig. 1. Schematic Illustration of Neuroprotective Flavonoids Against Oxidative Stress-induced Neurodegeneration
Flavonoids, a class of polyphenolic compounds, exhibit significant cognitive potential, partly through their ability to enhance antioxidant defenses and protect against oxidative stress3. Quercetin, a naturally occurring flavonoid, has been extensively researched for its neuroprotective and anti-inflammatory properties and promising tool in treating neurodegenerative diseases such as Alzheimer’s and Parkinson’s4. Quercetin-3-galactoside is the predominant glycosidic form of quercetin present in cranberries5. The main structural difference lies in the sugar moiety attached in place of the 3’ OH group connected by a glycosidic bond on the central-C-ring of the core quercetin structure (Fig. 2).

Fig. 2. Quercetin and Quercetin-3-galactoside Chemical Structure
Quercetin glycosides are more commonly found in derivatives than free form quercetin6. Glycosides are more water-soluble than their respective non-sugared aglycones and have generally been reported to possess greater bioavailability in vivo7. Although glycosides often have reduced antioxidant activity, their structural differences can enhance compound stability and absorption into the bloodstream, highlighting their potential as a preferred alternative in targeting specific drug properties7.
Although quercetin has been investigated for its inhibitory effects on neurodegenerative enzymes, there is limited research investigating quercetin-3-galactoside’s potential as an inhibitor of neurodegenerative-related enzymes. Acetylcholinesterase (AChE) is an enzyme responsible for hydrolyzing acetylcholine, a critical neurotransmitter that plays a role in memory, learning, and attention8. Butyrylcholinesterase (BChE) is a nonspecific enzyme that catalyzes the hydrolysis of choline and non-choline esters, including acetylcholine9. Low levels of acetylcholine are characteristic of individuals affected by Alzheimer’s disease8. Monoamine oxidase (MAO) exists as two isoforms: MAO-A, which oxidizes serotonin, norepinephrine, and epinephrine, and MAO-B responsible for oxidizing dopamine10. Monoamine oxidases are relevant to Parkinson’s disease, a neurological disease impacted by reduced levels of dopamine, norepinephrine, and serotonin11. Targeting these enzymes and discovering these compounds’ inhibitory potential could highlight their therapeutic relevance.
Comparing isolated fractions of quercetin and its glycosides’ antioxidant capacity and neuroprotective potential is relevant to the development of modern therapeutics that can be used in combination with other potential natural compounds to address root mechanisms of disease. It is important to explore the relationship between flavonoids and their glycosides and how structural differences can impact antioxidant and neuroprotective properties to optimize treatment. In addition to its potential in modern therapeutics, findings from this study, if successful, could influence dietary recommendations to reduce the risk of onset of neurodegenerative diseases12.
Experimental
Preparation of Crude Extracts
The Mullica Queen (MQ) cranberry cultivar was collected from cranberry bogs at the Cranberry Station in Wareham, MA, in September 2023. Cranberry pomace samples, consisting of a mixed variety of cultivars, were obtained from Ocean Spray. All samples were flash-frozen in liquid nitrogen and stored at -20°C. Samples were ground, lyophilized, and further ground into a fine powder. Dried fruit powder (40 g) was dissolved (400 mL) in an extraction solvent composed of acetone/methanol/distilled water/formic acid (40:40:19:1 v/v). The mixture was stirred for 1 hour, sonicated for 30 minutes, and refrigerated overnight. The following day, the sample was vacuum filtrated, and the solid residue was re-extracted using half the original solvent volume (200 mL). The same process was repeated the following day with half the original solvent amount for a total of three extractions. All filtrates were combined, rotary evaporated, frozen, and
lyophilized for further analysis.
Isolation of Concentrated Fruit Extracts
A Diaion HP-20 chromatography column was prepared for the purification of polyphenolic compounds from the Mullica Queen (MQ) extract. A glass chromatography column was packed with clean sand and glass wool. The resin was pretreated by activating with methanol for 15 minutes and washing with distilled water prior to being transferred into the column, allowing the resin to settle. Crude extract (20 g) was dissolved in a minimal volume of methanol/formic acid (99.9:0.1v/v) and was loaded onto the column and allowed to absorb into the packing. After 15 minutes had elapsed, the elution of free sugars was initiated using distilled water until the eluate appeared colorless; colorless eluates were discarded. Colored bands containing polyphenols and terpenoids were eluted using methanol/formic acid (99.9: 0.1 v/v). Acetone was used to elute the residual yellow that appeared in the packing. All eluates were collected, combined, and rotary evaporated to remove solvent. Samples were freeze-dried to obtain a concentrated powder and stored at 0°C.
Isolation of Flavonol Fractions
Sephadex LH-20 (3.0 x 22.0 cm), a hydroxypropylated, cross-linked dextran resin with an exclusion limit of 4-5 kDa and flow rate capacity of < 60 cm/hr, was used to isolate flavonoid derivatives. A glass column is packed with glass wool and sand. The Sephadex resin (40 g) was pretreated by swelling in 70% MeOH for 3 hours at room temperature. Particles were decanted, resuspended, and poured into the column, which was allowed to stand overnight in 70% MeOH before separation. Concentrated fruit extract (1 g) was dissolved in a minimal volume of formic acid/water/methanol (1:50:48.9 v/v/v) and loaded onto the column. After 15 minutes of absorption, phenolic compounds were eluted using 70% MeOH, and colored bands were collected separately. Brown bands containing proanthocyanidins were eluted with 70% acetone, followed by 100% acetone to elute any remaining proanthocyanidins. All collected fractions were rotary evaporated, frozen, lyophilized, and stored for further analysis.
Identification of Compounds by HPLC
Chromatographic Conditions
High-performance liquid chromatography (HPLC) analysis was performed using an Atlantis T3 C18 column (4.6 x 150 mm, 3 µm) on a Waters HPLC system equipped with a pump (Empower e2695), a photodiode array (PDA) detector (Waters 2998), an online degasser, and an autosampler. Mobile phase A consisted of water/phosphoric acid (99.5:0.5, v/v), and mobile phase B contained water/acetonitrile/glacial acetic acid/phosphoric acid (50:48.5:1.0:0.5, v/v/v/v). A reverse-phase gradient program was used, developed by Liang Xue 2021 and modified by Maureen Otieno (2023). The injection volume was 20 µL, with a flow rate of 0.900 mL/min and a total run time of 31 minutes. Chromatographs were recorded at 520, 355, 310, 280 nm to measure anthocyanidins, flavonols, phenolic acids, and proanthocyanidins, respectively.
Standard Preparation
A stock solution of the standard was prepared by dissolving 2 mg of each standard in 2 mL of HPLC-grade methanol to obtain a concentration of 1000 ppm. Serial dilutions were performed to obtain concentrations of 100, 50, 25, 12.5, 6.25, and 3.13 ppm. Solutions were sonicated and filtered through a 0.45 mm syringe filter before injecting 20 µL into the HPLC system.
Sample Preparation
Extract samples (2 mg/5 mg/10 mg) were dissolved in 1 mL of methanol to obtain the desired concentration. Solutions were sonicated and filtered through a 0.45 mm PTFE syringe filter and 20 µL of each sample was injected into the HPLC system.
Folin-Ciocalteau Assay
The quantification of total polyphenolic content in both the crude fruit and pomace extracts was measured using a modified protocol of the Folin-Ciocalteau assay as described by Ainsworth et al.13. 20 mg of cranberry/cranberry pomace powder samples were weighed in triplicate and dissolved in 2 mL of ice-cold 95% v/v methanol to obtain a concentration of 10 mg/mL. Samples were ultrasonicated for 30 minutes and refrigerated overnight. The following day, samples were centrifuged for 5 minutes at 10,250 rpm. 40 µL of the supernatant was collected into duplicate Eppendorf tubes and reacted with 800 µL of 10% v/v F-C reagent. The solution was vortexed and allowed to stand for five minutes. 800 µL of sodium carbonate was then pipetted, followed by 360 µL of distilled water. A blank sample was prepared by substituting the stock solution with 40 µL of 95% v/v methanol. Samples were incubated in the dark at room temperature for two hours before measuring absorbance. 200 µL of respective solutions were pipetted in triplicate onto a 96-well microplate. Absorbance was measured at 760 nm using a SpectraMax 190 microplate reader. Total phenolic content was calculated as gallic acid equivalents (GAE) using the regression equation between gallic acid standards at A760 nm, using the following calculation:
T = C/C1 X MW
T = total phenolic content in mg/g, in GAE (gallic acid equivalents)
C = concentration of gallic acid established from the calibration curve in mg/m
C1 = concentration of the extract in mg/mL
MW = the molecular weight of gallic acid
DPPH Radical Scavenging Assay
The DPPH radical scavenging activity of both quercetin and quercetin-3-galactoside fractions was evaluated according to a modified method of Baliyan et al.14. 5 mg of each respective fraction was dissolved in 20 mL of methanol, vortexed briefly, and subjected to ultrasonication to ensure samples were fully dissolved and obtain a concentration of 250 µg/mL. From this stock solution, a serial dilution was performed to obtain the following range of concentrations: 250, 125, 62.5, 31.25, 15.63, 7.81, 3.91, 1.95 µg/mL. A DPPH solution (300 µM)was prepared by dissolving 5 mg of 2,2-diphenyl-1-picrylhydrazyl in 50 mL of methanol. 100 µL of each respective concentration was pipetted in triplicate onto a 96-well microplate. 25 µL of DPPH solution was added and mixed by pipetting. A control solution was prepared by pipetting 100 µL of methanol with 25 µL of DPPH. The blank solution contained 125 µL of methanol. The plate was incubated in the dark at room temperature for 30 minutes, and absorbance was measured at 517 nm using a SpectraMax 190 microplate reader. The following formula was used to compute percent inhibition:
DPPH % Inhibition = A0 – (A1 -Ab)/A0 x 100%
A0: Control absorbance with no radical scavenger (DPPH + MeOH)
A1: Sample absorbance (DPPH + scavenger)
Ab: Blank absorbance (MeOH)
Ferric Reducing Antioxidant Power
The ferric reducing power of quercetin and quercetin-3-galactoside fractions was measured using a modified version of the method described by Gashaye et al.15. Samples were prepared by dissolving 5 mg of extract in 20 mL of methanol, briefly vortexing, followed by ultrasonicating to obtain a concentration of 250 µg/mL. From this stock solution, a serial dilution was performed to obtain the following range of concentrations: 250, 125, 62.5, 31.25, 15.63, 7.81, 3.91, 1.95 µg/mL. A FRAP working solution was prepared containing 25 mL of acetate buffer (300 mM, pH 3.6), 2.5 mL of 10 mM TPTZ in 340 mM HCl, and 2.5 mL of 20 mM FeCl3 • 6H2O solution (10:1:1 v/v/v). This working solution was designated for usage within three hours of preparation. 20 µL of the respective sample was pipetted in triplicate into a 96–well microplate, followed by the addition of 180 µL of FRAP working solution and thoroughly mixed by pipetting. As a control, 20 µL of methanol and 180 µL of FRAP working solution were plated in triplicate. A blank solution consisting of 200 µL of methanol was plated in triplicate to account for background absorbance. The plate was incubated at room temperature in the dark for 30 minutes. Absorbance was measured at 593 nm using a SpectraMax 190 microplate reader. Results were calculated as percent reducing power using the following formula:
FRAP % = A1 -Ab/A1 x 100%
A1: Sample absorbance (FRAP + reducer)
Ab: Blank absorbance (MeOH)
ABTS Radical Scavenging Assay
The relative ability of the flavonol fractions to scavenge ABTS was determined using a colorimetric assay as described by Tomasina et al16. A 7 mM ABTS stock solution was prepared by dissolving 0.1921 g of ABTS in 50 mL phosphate-buffered saline (PBS). A 2.45 mM potassium persulfate solution was prepared by dissolving 0.0331 g of potassium persulfate in 50 mL PBS. Equal aliquots (50 mL) of 7 mM ABTS and 50 mL 2.45 mM potassium persulfate solution were mixed and allowed to stand in the dark at room temperature for 16 hours to generate the ABTS•+ radical cation. The resulting ABTS•+ solution was diluted with 0.01 M PBTS to an absorbance of 0.70 ± 0.02 at 734 nm. Once adjusted, the solution was left to stabilize for 30 minutes and monitored for significant changes in absorbance. The reaction was initiated by reacting 190 µL of diluted ABTS•+ reagent with 10 µL of extract in triplicate wells of a 96-well microplate. A control was prepared using 10 µL of methanol in addition to 190 µL of ABTS•+, with 200 µL of methanol serving as the blank. Absorbance was read at 734 nm using a SpectraMax190 microplate reader. The following formula was used to compute percent inhibition:
% Inhibition = A0 – (A1 -Ab)/A0 x 100%
A0: Control absorbance with no radical scavenger (ABTS•+ + MeOH)
A1: Sample absorbance (ABTS•+ + scavenger)
Ab: Blank absorbance (MeOH)
Acetylcholinesterase In Vitro Enzyme Assay
The AChE inhibitory activities of the isolated fractions were examined using Ellman’s method18 in conjunction with the AmpliteTM Colorimetric Acetylcholinesterase Assay Kit (AAT Bioquest, Inc.), and optimized based on the procedure described by Koseki et al17. One milligram of extract was dissolved in 1 mL of DI water with 0.4% DMSO. A series dilution was performed to obtain the following concentrations: 250, 125, 62.5, 31.25, 15.63, 7.81, 3.91, 1.95 µg/mL. 10 µL of the sample solutions were pipetted into triplicate onto a 96-well microplate, followed by 30 µL of assay buffer and 10 µL of acetylthiocholinesterase (200 mU/mL in assay buffer). Galantamine (0.1 mg/mL), a selective inhibitor of AChE, was used as a positive control. Samples were incubated in the dark at room temperature for 20 minutes to facilitate binding. The reaction was initiated by adding the working reagent containing 5,5’dithiobis(2-nitrobenzoic acid) and acetylthiocholine iodide, which, upon hydrolysis, forms thiocholine. Thiocoline reacts with the reagent to form a yellow 5-thio-2-nitrobenzoate anion. After 30 minutes of incubation, absorbance was measured at 405 nm using the SpectraMax 190 microplate. The AChE inhibitory activity was calculated as follows19:
Percent Inhibition = E x S/E x 100%
E: Activity of enzyme without the inhibitor
S- Sample Absorbance
*E and S were each subtracted by their respective blank
Results and Discussions
HPLC Quantification of Polyphenolic Compounds in MQ & CP
Polyphenolic constituents were characterized using reversed-phase high-performance liquid chromatography (HPLC) to compare both Mullica Queen (MQ) and cranberry pomace (CP) extracts for their polyphenolic content at various wavelengths. Anthocyanins. flavonols, phenolic acids, and proanthocyanidin chromatograms were extracted at 520, 355, 310, and 280 nm, respectively, and compared to standard compounds for identification. The detection of these polyphenolic compounds is relevant to their bioactive potential and provides insight into their active antioxidant components. Compounds marked in orange were identified using a published reference20 or require standard spiking. Relevant peak wavelengths are detailed below the chromatograms.

Fig. 3. HPLC Chromatogram of Mullica Queen (MQ) Fruit Extract (Run 3, 5 mg/mL) at 520 nm

Fig. 4. HPLC Chromatogram of Cranberry Pomace (CP) Extract (Run 3, 10 mg/mL) at 520 nm
HPLC chromatograms were extracted at 355 nm to reveal flavonoids present in both MQ and CP extracts, with several peaks corresponding to known flavonol standards. Peaks observed at retention times 11.79 min and 13.16 min in the MQ fruit extract were identified as myricetin-3-O-galactoside and quercetin-3-O-galactoside, respectively (Fig. 5). The aglycones of these compounds, myricetin and quercetin, were confirmed to be present in the CP extract at later elution times of approximately 18.07 min and 22.21 min, respectively (Fig. 6).

Fig. 5. HPLC Chromatogram of Mullica Queen (MQ) Fruit Extract (Run 3, 5 mg/mL) at 355 nm
Although the cranberry pomace was run at a higher concentration, the MQ extract demonstrates a broader distribution and abundance of flavonols. The difference in composition contributes to their antioxidant performance. The profiling of the whole extracts confirms the presence of the target quercetin aglycone and its glycoside, but also provides information as to other phytochemicals that may contribute to their observed antioxidant effect.

Fig. 6. HPLC Chromatogram of Cranberry Pomace (CP) Extract (Run 3, 10 mg/mL) at 355 nm

Fig. 7. HPLC Chromatogram of Mullica Queen (MQ) Fruit Extract (Run 3, 5 mg/mL) at 310 nm

Fig. 8. HPLC Chromatogram of Cranberry Pomace (CP) Extract (Run 3, 10 mg/mL) at 310 nm

Fig. 9. HPLC Chromatogram of Mullica Queen (MQ) Fruit Extract (Run 3, 5 mg/mL) at 280 nm

Fig. 10. HPLC Chromatogram of Cranberry Pomace (CP) Extract (Run 3, 10 mg/mL) at 280 nm
Quantification of Polyphenolic Compounds in MQ Extract
Quantitative analysis of the MQ extract reveals that quercetin-3-O-galactoside was the most abundant polyphenolic compound with an average concentration of 13.9 ± 0.19 mg/g of desugared extract. Quercetin glycosides constituted much of the polyphenolic content in this extract. Although glycoside derivatives are present in high concentrations in this sample, trace amounts of free quercetin were also detected, though present at significantly lower concentrations. CP extract likely contains higher levels of quercetin aglycones, potentially due to processing conditions during juice extraction, where these water-insoluble aglycones may be concentrated in the pomace.
Table 1. Mullica Queen Polyphenolic Content Quantification
| Compound |
Average Concentration (mg analyte/g of Desugared Extract) |
|
FLAVONOLS
|
| Quercetin |
0.33 ± 0.00 |
| Quercetin-3-O-Galactoside |
13.9 ± 0.19 |
| Myricetin-3-O-Galactoside |
12.2 ± 0.09 |
| Isorhamnetin |
0.11 ± 0.01 |
|
PHENOLIC ACIDS
|
| p-Coumaric Acid |
2.55 ± 0.02 |
| Ideain Chloride |
0.51 ± 0.0 |
| Peonoidin-3-O-Galactoside Chloride |
6.65 ± 0.04 |
|
ANTHOCYANINS
|
| Cyanidin-3-O-Galactoside |
0.51 ± 0.0 |
| Peonidin-3-O-Galactoside |
0.60 ± 0.0 |
|
PROANTHOCYANINS
|
| PACs A |
7.39 ± 0.02 |
| PACs B |
3.5 ± 0.35 |
Isolation and Confirmation of Quercetin & Quercetin-3-galactoside in Isolated Fractions
Fractionation of the fruit and pomace extracts using Sephadex gel filtration chromatography was proven successful in the isolation of both quercetin and its glycoside (Table 2). Sephadex fractionation relies on size exclusion principles, where larger molecules elute first and smaller molecules are retained longer in the porous matrix. A peach-colored eluate corresponding to 70%methanol Eluate IV was the final fraction eluted with this solvent and confirmed to contain quercetin-3-galactoside in this MQ fraction. The compound’s strong retention onto the column indicates strong interactions with the Sephadex matrix. HPLC spectral data were used for identification as the compound strongly absorbed at 355.3 nm, corresponding to standard data and retention times (Fig. 11).
Table 2. Mullica Queen Sephadex LH-20 Fractionation Output


Fig. 11. MQ 70% Methanol Eluate IV Fraction Chromatogram (Run 3, 2 mg/mL) at 355 nm
A yellow-colored eluate corresponding to 70% Acetone Eluate III was confirmed to contain the aglycone quercetin as the main active component in this CP fraction. Spectral data showed a strong absorbance at 363.6 nm corresponding to the standard quercetin wavelength and retention times (Fig. 12). Solubility differences between quercetin and its more polar glycoside impact their interaction with the nonpolar stationary phase. Polar mobile phase solvent, 70% methanol, facilitates the elution of the more polar glycoside, whereas 70% acetone is strong enough and less polar to elute the aglycone with reduced polarity.
INSERT FIGURE 12 HERE
Fig. 12. CP 70% Acetone Eluate III Fraction Chromatogram (Run 3, 10 mg/mL) at 355 nm
Determination of Total Phenolic Content
Phenolic compounds are critical for antioxidant defense to neutralize free radicals. The Folin-Ciocalteau (F-C) assay is a widely used method to measure total phenolic content (TPC). Reaction of phenolic compounds reveals their antioxidant power based on the reduction of yellow phosphotungstate-phosphomolybdate complex by antioxidants that reduce the complex to a blue chromagen measured at 760 nm21. Reducing capacities of the powdered CP and MQ extracts were measured to compare the broader polyphenolic composition of the extracts the quercetin and its glycosides were isolated. The total phenolic content was measured in milligrams of gallic acid per gram of dry powder. The MQ fruit extract exhibited a higher total phenolic content compared to the CP extract, which is consistent with the presence of more diverse polyphenolic compounds, suggesting the fruit may serve as a richer source of flavonol glycosides. The TPC of the MQ powder was significantly higher (192.1 ± 1.53 mg/g ) than CP (137.3 ± 2.28).

Fig. 13. Total Phenolic Content in CP & MQ
DPPH Free Radical Scavenging Antioxidant Activity
Another commonly used bioanalytical method to measure antioxidant activity is the 1,1-diphenyl-2 picrylhydrazyl (DPPH) assay. This method evaluates antioxidant capacity based on spectrophotometric measurements of antioxidants’ ability to scavenge DPPH free radicals. The underlying mechanism involves the reaction of DPPH· radicals with hydrogen-donating antioxidants to form a reduced hydrazine compound (DPPH-H). Upon the formation of hydrazine, a neutralized, yellow-colored solution appears, indicating the radical neutralization from its original dark purple complex, spectrophotometrically observed at 517 nm22. This assay was employed to compare the antioxidant capacity of de-sugared CP and MQ extracts, as well as their respective quercetin and quercetin glycoside fractions.

Fig. 14. (a) Percent Inhibition of DPPH radical by CP and MQ de-sugared extracts. (b) Percent inhibition of DPPH radical by CP Quercetin, and MQ Quercetin-3-Galactoside fractions
Results indicate that the MQ extract exhibited a higher percentage of DPPH radical inhibition than the CP extract, though data did not significantly vary (Fig. 14a). Both extracts displayed dose-dependent behavior with increasing concentrations resulting in greater inhibition of DPPH radicals. Analysis of the CP quercetin and MQ quercetin-3-galactoside fractions revealed significant differences in antioxidant activity at lower concentrations, as higher concentrations were omitted to demonstrate a more pronounced difference. CP-derived quercetin demonstrated higher antioxidant activity with respect to its glycoside fraction, despite originating from the CP extract with overall lower antioxidant activity and TPC. At 31.3 μg/mL, CP quercetin exhibited 81.0 ± 12.1% inhibition, outperforming its glycoside, which only reached 73.7 ± 3.79 % at the same concentration (Fig. 14b).
Ferric Reducing Antioxidant Power
Further antioxidant analysis was performed using the Ferric Reducing Antioxidant Power assay(FRAP), which measures antioxidant reduction potency based on the reduction of a colorless Fe3+- TPTZ complex into an intense blue Fe2+-TPTZ in the presence of antioxidants. This reduction in acidic medium is measured spectrophotometrically at 593 nm. Notably, the ferricreducing antioxidant power between the desugared CP and MQ extracts demonstrates differing results in respect to the DPPH assay.

Fig. 15. (a) Ferric reducing antioxidant power by CP and MQ de-sugared extracts (b) Ferric-reducing antioxidant power by CP Quercetin and MQ Quercetin-3-Galactoside fractions
Results show CP extract exhibited greater ferric reducing antioxidant power at varying concentrations (250 – 3.91 μg/mL). Although it’s important to note that the dose-dependent response is not as significant for CP extracts as previously noted, considering lower concentrations still exhibited significant reduction potential with respect to MQ (Fig. 15a). Analysis of the fractions reveals CP quercetin demonstrates significantly higher ferric reducing antioxidant power with respect to its MQ quercetin-3-galactoside fraction. At 31.3 μg/mL, CP quercetin exhibited 57.4 ± 4.29% reducing power, outperforming its glycoside, which only reached 43.5 ±1.28 % at the same concentration (Fig. 15b).
ABTS Radical Scavenging Activity
To further validate the antioxidant potential of the isolated fractions, the 2,2-azino-bis-3-ethylbenzothiazoline-6-sulphonic acid (ABTS)assay was utilized. The principle of this method relies on the electron transfer of antioxidants in reducing ABTS radical cation (ABTS•+) to its colorless, neutralized form with a decreased absorbance measured spectrophotometrically at 734 nm. Both CP quercetin and MQ quercetin-3-galactoside fractions demonstrated strong free radical scavenging at 250 μg/mL, with ABTS inhibition values of 98.2 ± 0.96 % and 95.9 ±4.88 %, respectively. CP quercetin maintained relatively higher activity, exhibiting 26.3 ±3.51% inhibition, outperforming its glycoside fraction, which showed lower inhibition at 24.9 ±2.39%. Findings from the ABTS assay, along with FRAP and DPPH results, support the conclusion that CP-derived quercetin exhibits stronger antioxidant activity than its glycosylated counterpart.

Fig. 16. Comparison of ABTS scavenging activity between MQ Quercetin-3-galactoside and CP Quercetin fractions
Inhibitory Effect on Acetylcholinesterase(AChE)
Acetylcholinesterase (AChE) is a neurodegenerative-associated enzyme that catalyzes the hydrolysis of acetylcholine, a neurotransmitter critical to memory, attention, and learning8. AChE inhibitors are used to treat Alzheimer’s disease by inhibiting the breakdown of acetylcholine. To assess their potential neuroprotective properties of cranberry and cranberry pomace-derived fractions, AChE-inhibitory activity was evaluated in vitro. This assay employed Ellman’s reagent to quantify thiocholine, a product of acetythiocholine hydrolysis by AChE. Thiocholine reacts with DTNB (5,5’-dithiobis (2-nitrobenzoic acid)) to produce a yellow complex measured at 405 nm.

Fig. 17. Inhibition of AChE activity by CP Quercetin
Using the AmpliteTM Colorimetric Acetylcholinesterase Assay Kit (AAT Bioquest, Inc.) with protocol adjustments based on a method described by Koseki et al18, CP-derived quercetin exhibited significant inhibitory activity. At a concentration of 250 μg/mL, this fraction achieved 59.0 ± 2.41% inhibition of AChE activity, while at a lower concentration, 31.3 μg/mL, the sample reached 8.85 ± 2.86% AchE inhibition. Galantamine, a clinically approved AChE inhibitor used in the treatment of dementia, served as the positive control. As subsequent trials were conducted, tests at higher concentrations with the CP quercetin extract and the evaluation of the inhibitory potential of the MQ quercetin-3-galactoside fraction demonstrated inconsistent results. A reduction in galantamine’s inhibitory effect was also observed during these trials, indicating partial degradation of the enzyme. Solubility issues also arose when dissolving the glycoside fraction, which required increased DMSO concentrations that could have impacted its inhibitory effects. Overall, while CP-derived quercetin shows promising inhibitory activity against AChE, this method requires further optimization to allow for accurate comparisons of fraction AChE inhibitory activity.
Conclusions
The results of this study suggest that cranberry pomace-derived quercetin exhibits stronger antioxidant activity than its glycosylated counterpart, quercetin-3-galactoside, isolated from Mullica Queen (MQ) fruit extract. HPLC profiling and fractionation confirmed these compounds as the primary active constituents of their respective extracts. Despite the CP powder having lower TPC than MQ, CP-derived quercetin consistently outperformed its glycoside-rich fraction in antioxidant assays (DPPH, FRAP, ABTS) and demonstrated moderate acetylcholinesterase(AChE) inhibitory activity. It should be noted that the DPPH antioxidant activity of the CP and MQ concentrated extracts themselves is relatively statistically equivalent, with the CP extract exhibiting greater ferric reducing antioxidant power maintained throughout lower concentrations. ABTS results show relatively similar potential in reducing ABTS radical cation, although CPquercetin still demonstrated higher inhibition than its glycoside. Results highlight CPquercetin’s neuroprotective potential through its ability to scavenge reactive oxygen species(ROS). The differences in activity between the aglycone and its glycoside are likely due to the absence of the sugar moiety. Findings from this study support the conclusion that glycosylation may reduce bioactivity. Future studies will explore their effects on additional neurodegenerative-related enzymes such as monoamine oxidases (MAOs) and butyrylcholinesterase, as well as potentially conducting in vivo studies to evaluate how glycosylation impacts absorption and therapeutic potential.
Acknowledgements
This work was supported by funding from the Office of Undergraduate Research at the University of Massachusetts Dartmouth and the UMass Cranberry Health Research Center. The author also gratefully acknowledges the support of Dr. Neto, Maureen Otieno, and the rest of the Neto lab research group.
References
(1) World Health Organization. (2007, February 27). Neurological disorders affect millions globally: WHO report. Www.who.int. https://www.who.int/news/item/27-02-2007-neurological-disorders-affect-millions-globally-who-report
(2) Arias-Sánchez, R. A., Torner, L., & Fenton Navarro, B. (2023). Polyphenols and Neurodegenerative Diseases: Potential Effects and Mechanisms of Neuroprotection.Molecules (Basel, Switzerland), 28(14), 5415. https://doi.org/10.3390/molecules28145415
(3) Ayaz, M., Sadiq, A., Junaid, M., Ullah, F., Ovais, M., Ullah, I., Ahmed, J., &Shahid, M. (2019). Flavonoids as Prospective Neuroprotectants and Their Therapeutic Potential in Aging Associated Neurological Disorders. Frontiers in aging neuroscience, 11, 155. https://doi.org/10.3389/fnagi.2019.00155
(4) Chiang, M. C., Tsai, T. Y., & Wang, C. J. (2023). The Potential Benefits of Quercetin for Brain Health: A Review of Anti-Inflammatory and Neuroprotective Mechanisms. International journal of molecular sciences, 24(7), 6328.
(5) Blumberg, J. B., Camesano, T. A., Cassidy, A., Kris-Etherton, P., Howell, A., Manach, C., Ostertag, L. M., Sies, H., Skulas-Ray, A., & Vita, J. A. (2013). Cranberries and Their Bioactive Constituents in Human Health. Advances in Nutrition, 4(6), 618–632. https://doi.org/10.3945/an.113.004473
(6) Kaushik, A., Chauhan, K., & Singh, S. (2023). Neuroprotective potential of quercetin as a nutraceutical targeting fused neuroinflammation in neurological disease (pp. 623–637). Academic Press. https://doi.org/10.1016/B978-0-323-90052-2.00029-9
(7) Xie, L., Deng, Z., Zhang, J., Dong, H., Wang, W., Xing, B., & Liu, X. (2022).Comparison of Flavonoid O-Glycoside, C-Glycoside, and Their Aglycones on Antioxidant Capacity and Metabolism during In Vitro Digestion and In Vivo. Foods (Basel, Switzerland), 11(6), 882.
8) Cleveland Clinic. (2022, December 30). Acetylcholine (ACh). Cleveland Clinic.
(9) ArborAssays. (2018, February 8). Cholinesterases: Neurotransmitter Control Systems – Arbor Assays. Arbor Assays.
(10) Chen, K., & Shih, J. C. (1997). Monoamine Oxidase A and B: Structure, Function, and Behavior. Advances in Pharmacology, 42(1054-3589), 292–296. ScienceDirect.
(11) Mayo Clinic. (2024, September 27). Parkinson’s Disease. Mayo Clinic.
(12) Román, S., Sánchez-Siles, L. M., & Siegrist, M. (2017). The importance of food naturalness for consumers: Results of a systematic review. Trends in Food Science &Technology, 67(0924-2244), 44–57. https://doi.org/10.1016/j.tifs.2017.06.010
(13) Ainsworth, E. A., & Gillespie, K. M. (2007). Estimation of total phenolic content and other oxidation substrates in plant tissues using Folin-Ciocalteu reagent. Natureprotocols, 2(4), 875–877. https://doi.org/10.1038/nprot.2007.102
(14) Baliyan, S., Mukherjee, R., Priyadarshini, A., Vibhuti, A., Gupta, A., Pandey, R.P., & Chang, C. M. (2022). Determination of Antioxidants by DPPH Radical Scavenging Activity and Quantitative Phytochemical Analysis of Ficus religiosa. Molecules (Basel, Switzerland), 27(4), 1326. https://doi.org/10.3390/molecules27041326
(15) Gashaye, M.B., Birhan, Y.S. Phytochemical constituents, antioxidant and antibacterial activities of Plectocephalus varians (A. Rich.) C. Jeffrey ex Cufod root extracts. BMC Complement Med Ther 23, 135 (2023). https://doi.org/10.1186/s12906-023-03919-8
(16) Tomasina, F., Carabio, C., Celano, L., & Thomson, L. (2012). Analysis of two methods to evaluate antioxidants. Biochemistry and molecular biology education: abimonthly publication of the International Union of Biochemistry and Molecular Biology, 40(4), 266–270. https://doi.org/10.1002/bmb.20617
(17) Ellman G, Courteny K, Anderes V, Featherstone R (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95
(18) Koseki, Y., Nishimura, H., Asano, R., Aoki, K., Shiyu, L., Sugiyama, R., &Yamazaki, M. (2025). Isolation of new indole alkaloid triglucoside from the aqueous extract of Uncaria rhynchophylla. Journal of natural medicines, 79(1), 28–35
(19) Samani, P., Costa, S., & Cai, S. (2023). Neuroprotective Effects of Blueberries through Inhibition on Cholinesterase, Tyrosinase, Cyclooxygenase-2, and Amyloidogenesis. Nutraceuticals, 3(1), 39-57.
(20) Wu, X., Xue, L., Tata, A., Song, M., Neto, C. C., & Xiao, H. (2020). Bioactive Components of Polyphenol-Rich and Non-Polyphenol-Rich Cranberry Fruit Extracts and Their Chemopreventive Effects on Colitis-Associated Colon Cancer. Journal of agricultural and food chemistry, 68(25), 6845–6853. https://doi.org/10.1021/acs.jafc.0c02604
(21) Pérez, M., Dominguez-López, I., & Lamuela-Raventós, R. M. (2023). The Chemistry Behind the Folin-Ciocalteu Method for the Estimation of (Poly)phenol Content in Food: Total Phenolic Intake in a Mediterranean Dietary Pattern. Journal of agriculturaland food chemistry, 71(46), 17543–17553